Recombinant Human CD55/DAF Protein, CF | R&D Systems 2009-CD-050/CF product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

R&D Systems

product type :

protein

product name :

Recombinant Human CD55/DAF Protein, CF

catalog :

2009-CD-050/CF

quantity :

50 ug

price :

432 USD

citations: 6

Reference
Simovic M, Falabella M, Le T, Dallelucca J, Li Y. Decay-Accelerating Factor Creates an Organ-Protective Phenotype after Hemorrhage in Conscious Rats. Int J Mol Sci. 2022;23: pubmed publisher
Park G, Kim D. MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells. Neoplasia. 2019;21:206-215 pubmed publisher
Li Y, Yang Z, Chavko M, Liu B, Aderemi O, Simovic M, et al. Complement inhibition ameliorates blast-induced acute lung injury in rats: Potential role of complement in intracellular HMGB1-mediated inflammation. PLoS ONE. 2018;13:e0202594 pubmed publisher
Bongoni A, Lu B, Salvaris E, Roberts V, Fang D, McRae J, et al. Overexpression of Human CD55 and CD59 or Treatment with Human CD55 Protects against Renal Ischemia-Reperfusion Injury in Mice. J Immunol. 2017;198:4837-4845 pubmed publisher
Ayala Lujan J, Vijayakumar V, Gong M, Smith R, Santiago A, Ruiz Perez F. Broad spectrum activity of a lectin-like bacterial serine protease family on human leukocytes. PLoS ONE. 2014;9:e107920 pubmed publisher
Weeks C, Moratz C, Zacharia A, Stracener C, Egan R, Peckham R, et al. Decay-accelerating factor attenuates remote ischemia-reperfusion-initiated organ damage. Clin Immunol. 2007;124:311-27 pubmed

product information

master code :

2009-CD/CF

SKU :

2009-CD-050/CF

product name :

Recombinant Human CD55/DAF Protein, CF

unit size :

50 ug

description :

The Recombinant Human CD55/DAF Protein, CF from R&D Systems is derived from NS0. The Recombinant Human CD55/DAF Protein, CF has been validated for the following applications: Binding Activity.

target :

CD55/DAF

category :

Proteins and Enzymes

buffer :

Lyophilized from a 0.2 ╡m filtered solution in PBS.

conjugate :

Unconjugated

species :

Human

observed molecular weight :

61-75 kDa, reducing conditions

theoretical molecular weight :

36.0 kDa

gene symbol :

CD55

details of functionality :

Measured by its binding ability in a functional ELISA. Recombinant Human CD55/DAF (Catalog # 2009-CD/CF) binds to Recombinant Human CD97 His-tag with an ED50 of 1.50-15.0 ╡g/mL.

endotoxin note :

<1.0 EU per 1 ╡g of the protein by the LAL method.

accessionNumbers :

P08174.4

applications :

Binding Activity

source long :

Mouse myeloma cell line, NS0-derived human CD55/DAF protein Human CD55 (Asp35-Ser353) Accession # P08174.4 DI 6-His tag N-terminus C-terminus

source short :

NS0

USD :

432 USD

alt names :

CD55, CD55 antigen, CD55 molecule, decay accelerating factor for complement (Cromer blood group), CR, CRdecay accelerating factor for complement (CD55, Cromer blood group system), CROMDAFcomplement decay-accelerating factor, DAF, decay accelerating factor for complement, TC

storage :

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.